Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (160)	1/5/2007 7:48:00 PM
From: Robohogs	Respond to of 397

I was relieved to see I broke even for the first week. If I had kept EXEL in I would have done better, but as I said the decision to kick it out was 1) belief rallys will be sold and 2) desire not to match all picks to consensus. That being said, of my 9 picks, 4 are consensus and 5 are not. I had 3 stocks up and 6 down and sure enough 2 of the gainers were not consensus although consensus pick MNTA and non-consensus VVUS were the big gainers and consensus pick COLY the big loser with big losses in non-consensus picks NKTR and ENCY. Jon

To: BulbaMan who wrote (160)	1/12/2007 11:48:23 PM
From: BulbaMan	Read Replies (1) \| Respond to of 397

1/12/07 Update It was an excellent week for biotechs, with the Nasdaq Biotech Index closing Friday up 4.09% YTD (vs. up 1.06% YTD at the prior Friday's close). The 31 Contest portfolios had a fine week as well and now show a median 2.43% YTD gain (vs. a -.20% YTD loss at the prior Friday's close). At week's end, 25 of the 31 Contest portfolios were in the black and 9 of the 31 were beating the NBI. Jacked up by GHDX and MEMY, Tiley's portfolio remained in first place, ending the week with a spectacular 16.1% YTD gain. In second place is yours truly, with my portfolio's 13.1% YTD gain nudging ahead of the STEVEL portfolio 11.8% YTD gain. By far, the biggest contributor to my portfolio's gain was my Canadian penny biotech stock, Inex Pharmaceuticals (IEX.TO), which soared after Tuesday's announcement of an expansion of their partnership with Alnylam. I should admit that a part of me had qualms about including a penny stock in my Contest portfolio. But I decided it was kosher because Inex is indeed a real biotech company, it's listed on the main Toronto Stock Exchange and I owned it in real life. I also gave my rationale for picking Inex when I posted my Contest stock picks. Hopefully, Inex will soon move up beyond the penny world and my guilt feelings will dissolve. Below is the Top Ten list on 1/12/07: 1/12/07 Rank Name Total 1 TILEY 16,105 2 BULBA 13,137 3 STEVEL 11,789 4 GENE 6,909 5 WILDER 6,620 6 MANNY 5,699 7 MIKE 4,953 8 FRED 4,811 9 CASA 4,423 10 SCARAM 4,075 (All corrections greatly appreciated.)